Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...
Halozyme is paying as much as $400 million for a drug delivery specialist that could boost its growth prospects, one analyst ...
The development of a brain tumor in a study participant led regulators to suspend a Hurler syndrome therapy in early testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results